WECARE Study Collaborative Group
Principal Investigator
Jonine L Bernstein (Mount Sinai School of Medicine, New York, USA).
Co-Principal Investigators
W Douglas Thompson, Chair of the Epidemiology and Biostatistics Core (University of Southern Maine, Portland, ME, USA), Robert W Haile (University of Southern California, Los Angeles, CA, USA), Leslie Bernstein, Chair of the Data Collection Core (University of Southern California, Los Angeles, CA, USA), and Patrick J Concannon, Chair of the Laboratory Core (Virginia Mason Research Center, Seattle, WA, USA).
Coordinating Centers
Susan L Teitelbaum (Project Director), Gertrud S Berkowitz (Epidemiologist), Xiaolin Liang (Informatics Specialist), Monica Katyal (Project Coordinator), and Stephanie Skoler (Project Coordinator) (Mount Sinai School of Medicine, New York, USA); Daniela Seminara (Program Officer) (National Cancer Institute, Bethesda, MD, USA).
Laboratories
Sharon Teraoka (Laboratory Director) (Virginia Mason Research Center, Seattle, WA, USA); Anh T Diep (Laboratory Director), Nianmin Zhou (Laboratory Manager), and Yong Liu (Director of Blood Processing) (University of Southern California, Los Angeles, CA, USA); Anne-Lise Børresen-Dale (Laboratory Director), and Laila Jansen (Laboratory Manager) (Norwegian Radium Hospital, Oslo, Norway); Barry S Rosenstein (Laboratory Director), and David P Atencio (Laboratory Manager) (Mount Sinai School of Medicine, New York, USA); Richard A Gatti (Consultant) (University of California at Los Angeles, CA, USA).
Data Collection Centers
Laura Donnelly (Project Manager), and Maya Mahue-Giangreco (Project Manager) (University of Southern Cali-fornia, Los Angeles, CA, USA); Jørgen H Olsen (Director), and Lene Mellemkjær (Project Manager) (Danish Cancer Society, Copenhagen, Denmark); Kathleen E Malone (Director), and Noemi Epstein (Project Manager) (Fred Hutchinson Cancer Research Center, Seattle, WA, USA); Hoda Anton-Culver (Director), and Joan Largent (Project Manager) (University of California at Irvine, Irvine, CA, USA); Charles F Lynch (Director), and Jeanne DeWall (Project Manager) (University of Iowa, Iowa City, IA, USA).
Radiation Core
Marilyn Stovall (Dosimetry Laboratory Director and Chair, Radiation Core) (University of Texas, MD Anderson Cancer Center, Houston, TX, USA); Roy E Shore (Epidemiologist) (New York University, New York, USA); John D Boice Jr (Consultant) (International Epidemiology Institute, Rockville, MD, and Vanderbilt University, Nashville, TN, USA).
Epidemiology and Biostatistics Core
Duncan C Thomas, and Bryan M Langholz (University of Southern California, Los Angeles, CA, USA).
Breast cancer incidence among A-T family members study investigators
Robert W Haile, Duncan C Thomas, and Leslie Bernstein (University of Southern California, Los Angeles, CA, USA); Richard A Gatti (University of California at Los Angeles, Los Angeles, CA, USA).
ATMvariants and breast cancer risk among women at high risk for breast cancer study investigators
G Chenevix-Trench, D Nyholt, and KK Khanna (Queensland Institute of Medical Research, Brisbane, Australia); A Jenkins, and JL Hopper (The University of Melbourne, Centre for Genetic Epidemiology, Victoria, Australia); C Scott, andJ Sambrook(Peter MacCallum Cancer Institute, Victoria, Australia); T Dörk (Medical School Hannover, Hannover, Germany).
Radiation exposure, ATMgene mutations and breast cancer risk study investigators
Annegien Broeks (Division of Experimental Therapy), Flora E van Leeuwen (Department of Epidemiology), and Laura J van't Veer (Department of Pathology) (The Netherlands Cancer Institute, Amsterdam, The Netherlands).
Role of the ATMgene in breast tumor development and radiation sensitivity study investigators
Janet Hall, Sandra Angèle, Michèle Vuillaume, and Philippe Tanière (International Agency for Research on Cancer, Lyon, France); Isabelle Treilleux, and Alain Brémond (Centre Régional Léon Bérard, Lyon, France); Jean-Pierre Gérard, and Pascale Romestaing (Service de Radiothérapie-Oncologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France).